BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 11355925)

  • 41. Prognostic factors in acute myeloid leukaemia.
    Löwenberg B
    Best Pract Res Clin Haematol; 2001 Mar; 14(1):65-75. PubMed ID: 11355924
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Acute myeloid leukaemia presenting as faecal incontinence.
    Lim H; Cho YS; Jang PM; Jung Kim H; Young Jang H
    Emerg Med J; 2007 May; 24(5):e30. PubMed ID: 17452690
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Acute myeloid leukaemia.
    Stevens RF
    Br Med Bull; 1996 Oct; 52(4):764-77. PubMed ID: 9039730
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Pediatric AML: past, present, and future.
    Onel K; Steinherz PG
    Cancer Invest; 2002; 20(7-8):1117. PubMed ID: 12449745
    [No Abstract]   [Full Text] [Related]  

  • 45. Therapy-related leukemia associated with alkylating agents.
    Davies SM
    Med Pediatr Oncol; 2001 May; 36(5):536-40. PubMed ID: 11340608
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Prognostic factors and risk-based therapy in pediatric acute myeloid leukemia.
    Meshinchi S; Smith FO; Arceci RJ
    Curr Oncol Rep; 2003 Nov; 5(6):489-97. PubMed ID: 14521808
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Randomised studies in acute myeloid leukaemia: the double truth.
    Frassoni F
    Bone Marrow Transplant; 2000 Mar; 25(5):471-3. PubMed ID: 10713620
    [No Abstract]   [Full Text] [Related]  

  • 48. Guidelines on the management of acute myeloid leukaemia in adults.
    ; Milligan DW; Grimwade D; Cullis JO; Bond L; Swirsky D; Craddock C; Kell J; Homewood J; Campbell K; McGinley S; Wheatley K; Jackson G
    Br J Haematol; 2006 Nov; 135(4):450-74. PubMed ID: 17054678
    [No Abstract]   [Full Text] [Related]  

  • 49. The treatment of acute leukaemia in adults: a perspective.
    Hagenbeek A; Löwenberg B; Sizoo W; van't Veer MB
    Neth J Med; 1987 Feb; 30(1-2):51-3. PubMed ID: 3473309
    [No Abstract]   [Full Text] [Related]  

  • 50. Pediatric haematopoiesis and related malignancies.
    Jin M; Xu S; An Q
    Oncol Lett; 2017 Jul; 14(1):10-14. PubMed ID: 28693128
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Patients entered into MRC AML trials are biologically representative of the totality of the disease in the UK.
    Moorman AV; Roman E; Cartwright RA; Morgan GJ
    Clin Lab Haematol; 2002 Aug; 24(4):263-5. PubMed ID: 12181033
    [No Abstract]   [Full Text] [Related]  

  • 52. Myeloid leukemia and allied syndromes.
    Chandra RK
    Indian J Pediatr; 1966 Mar; 33(218):94-5. PubMed ID: 5220212
    [No Abstract]   [Full Text] [Related]  

  • 53. Proteomic profiling and bioinformatics analysis identify key regulators during the process from fanconi anemia to acute myeloid leukemia.
    Hou H; Li D; Gao J; Gao L; Lu Q; Hu Y; Wu S; Chu X; Yao Y; Wan L; Ling J; Pan J; Xu G; Hu S
    Am J Transl Res; 2020; 12(4):1415-1427. PubMed ID: 32355551
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Thiopurine Prodrugs Mediate Immunosuppressive Effects by Interfering with Rac1 Protein Function.
    Shin JY; Wey M; Umutesi HG; Sun X; Simecka J; Heo J
    J Biol Chem; 2016 Jun; 291(26):13699-714. PubMed ID: 27189938
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Acute myeloid leukaemia in children.
    Langmuir PB; Aplenc R; Lange BJ
    Best Pract Res Clin Haematol; 2001 Mar; 14(1):77-93. PubMed ID: 11355925
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Curing childhood acute myeloid leukemia (AML) at the half-way point: promises to keep and miles to go before we sleep.
    Woods WG
    Pediatr Blood Cancer; 2006 May; 46(5):565-9. PubMed ID: 16261562
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Chemotherapy for myeloid malignancy in children with Fanconi anemia.
    Mehta PA; Ileri T; Harris RE; Williams DA; Mo J; Smolarek T; Auerbach AD; Kelly P; Davies SM
    Pediatr Blood Cancer; 2007 Jun; 48(7):668-72. PubMed ID: 16609946
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Allogeneic and autologous bone marrow transplantation after consolidation therapy in high-risk acute myeloid leukemia in children. Towards a risk-oriented therapy.
    Ortega JJ; Díaz de Heredia C; Olivé T; Bastida P; Llort A; Armadans L; Torrabadella M; Massuet L
    Haematologica; 2003 Mar; 88(3):290-9. PubMed ID: 12651268
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Therapy-related myeloid leukaemia: a model for leukemogenesis in humans.
    Larson RA; Le Beau MM
    Chem Biol Interact; 2005 May; 153-154():187-95. PubMed ID: 15935816
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Treatment of childhood acute myeloid leukemia.
    ter Bals E; Kaspers GJ
    Expert Rev Anticancer Ther; 2005 Oct; 5(5):917-29. PubMed ID: 16221060
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.